mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.005 |
mRNA |
piperlongumine |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.005 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.099 |
0.005 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.006 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.094 |
0.006 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.006 |
mRNA |
BRD-K24690302 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.008 |
mRNA |
KIN001-270 |
GDSC1000 |
pan-cancer |
AAC |
0.089 |
0.008 |